| MeSH term | MeSH ID | Detail |
|---|---|---|
| Biliary Atresia | D001656 | 4 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Bone Diseases, Developmental | D001848 | 2 associated lipids |
| Bone Diseases, Endocrine | D001849 | 1 associated lipids |
| Bone Diseases, Metabolic | D001851 | 9 associated lipids |
| Bone Neoplasms | D001859 | 5 associated lipids |
| Bone Resorption | D001862 | 7 associated lipids |
| Cachexia | D002100 | 21 associated lipids |
| Calcinosis | D002114 | 5 associated lipids |
| Carcinoid Heart Disease | D002275 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhou QL et al. | Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. | 2016 | Mol Med Rep | pmid:27357904 |
| Wang C et al. | Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. | 2016 | Med. Sci. Monit. | pmid:26939934 |
| Lin J et al. | Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. | 2016 | Nat Commun | pmid:26923114 |
| D'Abramo A et al. | Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. | 2016 | PLoS ONE | pmid:26913505 |
| Lu J et al. | Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. | 2016 | Exp. Biol. Med. (Maywood) | pmid:26908571 |
| Stuss M et al. | Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. | 2016 | Endokrynol Pol | pmid:26884284 |
| Gluba-Brzózka A et al. | Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. | 2016 | Lipids Health Dis | pmid:26843213 |
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Bumdelger B et al. | Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. | 2016 | PLoS ONE | pmid:26783750 |
| Owen S et al. | Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. | 2016 | Int. J. Oncol. | pmid:26781475 |
| Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
| Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
| Theodoro LH et al. | Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. | 2016 | J. Periodont. Res. | pmid:26750739 |
| Totoson P et al. | Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. | 2016 | PLoS ONE | pmid:26761790 |
| Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
| Alam I et al. | Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. | 2016 | Endocrinology | pmid:26584014 |
| Mitchell JA et al. | Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. | 2016 | J. Bone Miner. Res. | pmid:26572781 |
| Melchiorre D et al. | Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. | 2016 | Haematologica | pmid:26494839 |
| Wang HL et al. | Protein biomarkers and microbial profiles in peri-implantitis. | 2016 | Clin Oral Implants Res | pmid:26424287 |
| Iezaki T et al. | The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. | 2016 | J. Bone Miner. Res. | pmid:26391411 |
| Liu G et al. | Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. | 2016 | Cell Tissue Res. | pmid:26004143 |
| Toffoli B et al. | Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. | 2016 | Mediators Inflamm. | pmid:28070143 |
| Chen H et al. | [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. | 2016 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:28070039 |
| Kainuma S et al. | Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. | 2016 | Mol Med Rep | pmid:26935864 |
| Shimazaki E et al. | TGF-β and Physiological Root Resorption of Deciduous Teeth. | 2016 | Int J Mol Sci | pmid:28035998 |
| Bolamperti S et al. | Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. | 2016 | Biomed Res Int | pmid:27999816 |
| Li Y et al. | Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. | 2016 | J. Genet. | pmid:27994198 |
| Gómez-Vaquero C et al. | Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. | 2016 | PLoS ONE | pmid:27911913 |
| Zhang L et al. | Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis. | 2016 | Cell. Physiol. Biochem. | pmid:27898403 |
| Biscetti F et al. | RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. | 2016 | Eur Rev Med Pharmacol Sci | pmid:27874938 |
| Liu FQ et al. | Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. | 2016 | Circ. J. | pmid:27867157 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| Li XJ et al. | Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. | 2016 | Int. J. Mol. Med. | pmid:27840967 |
| Zhou J and Zhao Y | Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. | 2016 | Med. Sci. Monit. | pmid:27828936 |
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |
| Ugay L et al. | Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. | 2016 | Chin. Med. J. | pmid:27411457 |
| Pellegrini GG et al. | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. | 2016 | Nutrients | pmid:27409635 |
| Nagy EE et al. | High circulating osteoprotegerin levels are associated with non-zero blood groups. | 2016 | BMC Cardiovasc Disord | pmid:27387019 |
| Zhang YY et al. | Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. | 2016 | Chin J Dent Res | pmid:27379348 |
| Songia P et al. | Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. | 2016 | J. Mol. Cell. Cardiol. | pmid:27338002 |
| Li Y et al. | OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. | 2016 | Medicine (Baltimore) | pmid:27336899 |
| Dolan EB et al. | Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. | 2016 | J R Soc Interface | pmid:27335224 |
| Kassem A et al. | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | 2016 | PLoS ONE | pmid:27311019 |
| Wang JH et al. | Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. | 2016 | Medicine (Baltimore) | pmid:27310953 |
| Yamada C et al. | TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. | 2016 | Int. J. Oncol. | pmid:27279422 |
| He M et al. | Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. | 2016 | Mol Med Rep | pmid:27277157 |
| Ye C et al. | [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27266195 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |
| Wei CC et al. | Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. | 2016 | Mediators Inflamm. | pmid:27199510 |
| Usategui-MartÃn R et al. | VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. | 2016 | Genet Test Mol Biomarkers | pmid:27172236 |